Key result
Low-dose EUK-8 improves survival and LV function while reducing hypertrophy and fibrosis in pressure-overloaded mice.
Why the study?
To identify apoptosis-inducing factor as a cardiac mitochondrial antioxidant and evaluate whether EUK-8 protects AIF-deficient myocardium against pressure overload.
Does EUK-8 improve survival and reduce cardiac remodeling in Hq mutant and WT mice subjected to pressure overload?
Population
Hq mutant mice and wild-type counterparts subjected to pressure overload
Comparison
Low-dose EUK-8 (25 mg/kg/day) vs vehicle
Design
Animal experimental study
Follow-up
4 weeks
Authors
Loading...
EUK-8 attenuates remodeling in overloaded mouse hearts; leaves open translation to human HF.
Does EUK-8 improve survival and reduce cardiac remodeling in Hq mutant and WT mice subjected to pressure overload?
EUK-8 protects against pressure overload-induced heart failure in both oxidative stress-prone Hq mice and WT mice, suggesting a potential therapeutic role for mitochondrial antioxidants in heart failure.
Empel et al. (2006) studied Pressure overload-induced heart failure. EUK-8 vs. Vehicle was evaluated on Survival, left ventricular end-systolic dimensions, fractional shortening, myocardial oxidant stress, cell death, cardiac hypertrophy and fibrosis. Low-dose EUK-8 ameliorated survival, improved left ventricular function, and attenuated cardiac hypertrophy and fibrosis in both Hq mutant and wild-type mice subjected to pressure overload.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: